Return to search

Efficacy of a therapeutic wand in addition to physiotherapy for treating bladder pain syndrome in women: a pilot randomized controlled trial

Yes / The aim of this study was to assess the feasibility of a randomized controlled trial
(PFM) treatment in women with bladder pain syndrome (BPS). Prolonged PFM
tension contributes to the bladder pain, urinary frequency and urgency associated
with BPS. Pelvic health physiotherapists routinely provide intravaginal myofascial
release (MFR) to the PFMs in order to effectively reduce symptoms. Rapid access
A TW was designed so as to allow men with chronic pelvic pain to self- treat,
and this may be effective in women with BPS. For 6 weeks, two groups received
weekly physiotherapist- provided MFR, and were monitored for a further 6- week
follow- up period. One group also used a TW at home three times a week throughout
the pilot. Weekly outcome measures of BPS symptoms and quality of life
were recorded. A clinically meaningful difference in Interstitial Cystitis Symptoms
Index and Interstitial Cystitis Problem Index score changes between groups was
group = 6.20 ± 0.83 and 5.00 ± 1.41, respectively), and a difference was observed
during the follow- up period (control group = 4.50 ± 1.73 and 4.00 ± 2.44, respecevents.
Using the TW appears to have enhanced physiotherapy treatment during
the initial 6 weeks, and improved symptoms during the 6- week follow- up period.
The TW may be a clinically useful tool for long- term management of BPS. The
feasibility of the study method was proven, some alterations were recommended
and an RCT is now warranted.

Identiferoai:union.ndltd.org:BRADFORD/oai:bradscholars.brad.ac.uk:10454/12129
Date17 October 2016
CreatorsBond, J., Pape, Hilary, Ayre, Colin A.
Source SetsBradford Scholars
LanguageEnglish
Detected LanguageEnglish
TypeArticle, Accepted manuscript
Rights(c) 2017 Chartered Society of Physiotherapists. Full-text reproduced with publisher permission., Unspecified

Page generated in 0.002 seconds